Medicine Description euglumide-plus 5mg
Euglumide Plus 5 mg Tablets is a medication that combines glibenclamide and metformin to manage type 2 diabetes effectively. Glibenclamide is a sulfonylurea that promotes insulin secretion from the pancreatic beta cells. It works by binding to specific receptors on these cells, enhancing their sensitivity to glucose, which increases insulin release in response to elevated blood sugar levels. Metformin, on the other hand, is biguanide that decreases hepatic glucose production, enhances insulin sensitivity in peripheral tissues, and improves glucose uptake by muscle cells. Together, these mechanisms help to lower blood glucose levels and improve overall glycemic control in patients with type 2 diabetes.
Indications and Uses of Euglumide Plus 5 mg Tablets
- Management of type 2 diabetes mellitus as part of a comprehensive treatment plan.
- Improvement of glycemic control in patients not adequately controlled by diet and exercise.
- Reduction of the risk of diabetes-related complications.
Side Effects of Euglumide Plus 5 mg Tablets
- Hypoglycemia (low blood sugar levels).
- Gastrointestinal disturbances, such as nausea, vomiting, or diarrhea.
- Weight gain in some patients.
- Possible allergic reactions, including skin rashes.
- Lactic acidosis, particularly in patients with renal impairment.
Storage and Handling
Store Euglumide Plus 5 mg Tablets at room temperature, away from direct sunlight and moisture. Keep out of reach of children. Do not use beyond the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should adhere to prescribed dietary guidelines and engage in regular physical activity to optimize treatment outcomes. Regular monitoring of blood glucose levels is recommended. Patients should be educated about recognizing signs of hypoglycemia and have a plan in place for managing low blood sugar. It’s essential to inform healthcare providers about any other medications being taken to avoid potential interactions.